Han S, He B, Peng Z, Tang Q, Zheng H, Weng L
Hua Xi Yi Ke Da Xue Xue Bao. 1993 Jun;24(2):160-2.
Thirteen human normal bone and fifteen bone tumor tissues were assayed for estrogen receptor (ER) by Dextran-coated Charcoal method (Scatchard plot). The results showed that the concentrations of ER in normal bone tissues (15.12 +/- 14.68 fmol/mg pro) were higher than that of bone malignant tumors (8.04 +/- 6.71 fmol/mg pro) P < 0.05). The binding dissociation constants (Kd) of ER in bone tumors (18.46 +/- 27.10 x 10(-11) mol/L) was lower than those in normal ones (39.91 +/- 20.13 x 10(-11) mol/L) (P < 0.025). The percentages for positive score of ER in normal and tumor ones (23.1%, 26.7%) were not significantly different (P > 0.05). Our study indicated that the variations of concentration and affinity of ER in bone related to the tumor incidence. That cytosol ER content was decreased in malignant bone tumors whereas that of affinity increase suggests an impairment or change of an intact receptor mechanism in this tissues.
采用葡聚糖包被活性炭法(Scatchard图)对13例人正常骨组织和15例骨肿瘤组织进行雌激素受体(ER)检测。结果显示,正常骨组织中ER浓度(15.12±14.68 fmol/mg蛋白)高于骨恶性肿瘤(8.04±6.71 fmol/mg蛋白)(P<0.05)。骨肿瘤中ER的结合解离常数(Kd)(18.46±27.10×10⁻¹¹ mol/L)低于正常骨组织(39.91±20.13×10⁻¹¹ mol/L)(P<0.025)。正常组织和肿瘤组织中ER阳性评分的百分比(23.1%,26.7%)差异无统计学意义(P>0.05)。我们的研究表明,骨中ER浓度和亲和力的变化与肿瘤发生率有关。恶性骨肿瘤中细胞溶质ER含量降低,而亲和力增加,提示该组织中完整受体机制受损或发生改变。